Roche Advances Alzheimer’s Disease Diagnosis with Breakthrough Blood Test

Alzheimer’s disease, blood test, Roche, Eli Lilly, FDA breakthrough device designation, pTau217, amyloid pathology, early diagnosis.

Revolutionizing Public Health: CBER’s Peter Marks and the Vision to Reduce FDA Visits

CBER, Peter Marks, FDA, public health, healthcare innovation, regulatory affairs, biologics, vaccines, medical devices, preventive measures.